Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Instone Real Estate partners with Ginkgo Fund on Düsseldorf “Benrather Gärten” development

Instone Real Estate partners with Ginkgo Fund on Düsseldorf “Benrather Gärten” development

ReutersReuters2026/08/10 05:38
  • Instone Real Estate partnered with Ginkgo Fund to jointly develop the “Benrather Gärten” redevelopment project in Düsseldorf.
  • Instone keeps overall project responsibility, remaining the main point of contact as the scheme moves through early-stage development.
  • The 15-hectare former industrial site is planned for a sustainable urban quarter with 800 to 1,000 apartments.
  • Demolition of existing buildings is scheduled to start in autumn, clearing the way for soil remediation and decontamination.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Instone Real Estate Group SE published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.